Skip to content
Disclosery

Invenomic Capital Management LP: ES position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Invenomic Capital Management LP on ES, newest first. How the timeline and the estimate are built.

Invenomic Capital Management LP held 0 ES shares at 2025-06-30 per its 13F-HR filed 2025-08-14.

the latest 13F is the newest step

  1. period ended2025-06-30
    13F 0 shares
    Change vs previous 13F -266,551 shares

    13F-HR 0001214659-25-012218 filed by Invenomic Capital Management LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-03-31
    13F 266,551 shares
    Change vs previous 13F -583,147 shares

    0.84% of the 13F portfolio, value $16,555,483.

    13F-HR 0001214659-25-007823 filed by Invenomic Capital Management LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2024-12-31
    13F 849,698 shares
    Change vs previous 13F +223,050 shares

    2.74% of the 13F portfolio, value $48,798,156.

    13F-HR 0001214659-25-002834 filed by Invenomic Capital Management LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2024-09-30
    13F 626,648 shares
    Change vs previous 13F not available

    2.35% of the 13F portfolio, value $42,643,396.

    13F-HR 0001214659-24-019131 filed by Invenomic Capital Management LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).